KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Net Income towards Common Stockholders (2018 - 2025)

Historic Net Income towards Common Stockholders for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.6 million.

  • Twist Bioscience's Net Income towards Common Stockholders rose 330.09% to -$30.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6116.66%. This contributed to the annual value of -$77.7 million for FY2025, which is 6279.57% up from last year.
  • Twist Bioscience's Net Income towards Common Stockholders amounted to -$30.6 million in Q4 2025, which was up 330.09% from -$27.1 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Net Income towards Common Stockholders ranged from a high of $20.4 million in Q2 2025 and a low of -$85.6 million during Q2 2024
  • Over the past 5 years, Twist Bioscience's median Net Income towards Common Stockholders value was -$42.4 million (recorded in 2022), while the average stood at -$42.9 million.
  • Per our database at Business Quant, Twist Bioscience's Net Income towards Common Stockholders plummeted by 6946.91% in 2021 and then skyrocketed by 12381.51% in 2025.
  • Twist Bioscience's Net Income towards Common Stockholders (Quarter) stood at -$45.6 million in 2021, then rose by 8.21% to -$41.8 million in 2022, then fell by 2.83% to -$43.0 million in 2023, then rose by 26.53% to -$31.6 million in 2024, then grew by 3.3% to -$30.6 million in 2025.
  • Its Net Income towards Common Stockholders was -$30.6 million in Q4 2025, compared to -$27.1 million in Q3 2025 and $20.4 million in Q2 2025.